Author: OurCrowd

[Alloy Therapeutics in Business Wire] Alloy Therapeutics unveils 2023 innovation roadmap across antibodies, TCRs, bispecifics, and genetic medicines

BOSTON–(BUSINESS WIRE)–Alloy Therapeutics, a biotechnology ecosystem company, announced its 2023 roadmap of new discovery technologies and services across a range of biologic modalities. Alloy will support its community of 140+ partners with deepened capabilities in its core antibodies offering, as well as substantial expansion into new modalities such as genetic medicines, leveraging an existing partnership announced with Dr. Sudhir Agrawal, a pioneer of gapmer antisense oligonucleotide (ASO) technology. Read...

Read More

[Stellar Cyber in Business Wire] Stellar Cyber Open XDR platform wins ASTORS awards in three categories

SANTA CLARA, Calif.–(BUSINESS WIRE)–Stellar Cyber, the innovator of Open XDR, has won three of American Security Today Magazine’s 2022 Homeland Security Awards (ASTORS). Stellar Cyber’s Open XDR platform won a Platinum Award for Best SIEM Solution and scored Gold awards for Best Cybersecurity Solution and Best Network Security Solution. Read more...

Read More